Journal of Pharmacokinetics and Pharmacodynamics

Springer Science+Business Media

Journal websitePeer review: Peer review
Evaluation status available after sign-in

About the journal

Journal of Pharmacokinetics and Pharmacodynamics is a journal published by Springer Science+Business Media in Netherlands. It is listed in MEDLINE according to the sources read. Declared publication charge: 3,860 EUR. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Springer Science+Business Media
ISSN
1567-567X · 1573-8744
Country
Netherlands
Access
Not open access / not declared
Declared publication charge
3,860 EUR
Declared peer-review model
peer_review

Index listings

  • MEDLINE · 2001-01-01
Indexing
MEDLINE
APC
3,860 EUR
Declared review time (DOAJ)
—
Actual review time (measured)
134 days received→accepted — computed from PubMed (n=96)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Works in OpenAlex

1228

Last recorded publication year

2026

Reported by OpenAlex in 1 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

77

i10-index

635

From OpenAlex open data (CC0).

Editorial & policy6
Observed digital preservation (Keepers registry)— snapshot 2026-10-05
CLOCKSSPortico
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
95%
ORCID iDs in current deposits
40%
Enrolled in Crossref Similarity Check
✓
Deposits licence metadata at Crossref
✓
Identity & continuity3
Source type
journal
NLM unique ID (PubMed)
101096520
Classification(no data)

No data available to the platform for this group

No platform data for: Classification — absence is not a judgment about the journal.

Subject areas

  • Pharmaceutical studies and practices
  • Statistical Methods in Clinical Trials
  • Statistical Methods in Clinical Trials
  • Statistical Methods in Clinical Trials
  • Pharmacogenetics and Drug Metabolism
  • Statistical Methods and Bayesian Inference
  • Pharmacogenetics and Drug Metabolism
  • Pharmacogenetics and Drug Metabolism
Show all subjects (75)
  • Statistical Methods and Bayesian Inference
  • Statistical Methods and Bayesian Inference
  • Computational Drug Discovery Methods
  • Computational Drug Discovery Methods
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • Monoclonal and Polyclonal Antibodies Research
  • Receptor Mechanisms and Signaling
  • Receptor Mechanisms and Signaling
  • Antibiotics Pharmacokinetics and Efficacy
  • Antibiotics Pharmacokinetics and Efficacy
  • Computational Drug Discovery Methods
  • Drug Transport and Resistance Mechanisms
  • Drug Transport and Resistance Mechanisms
  • Biosimilars and Bioanalytical Methods
  • Antibiotics Pharmacokinetics and Efficacy
  • Optimal Experimental Design Methods
  • Optimal Experimental Design Methods
  • Analytical Chemistry and Chromatography
  • Analytical Chemistry and Chromatography
  • Mathematical Biology Tumor Growth
  • Protein purification and stability
  • Protein purification and stability
  • Statistical Methods and Inference
  • Statistical Methods and Inference
  • Cardiac electrophysiology and arrhythmias
  • Cardiac electrophysiology and arrhythmias
  • Drug Transport and Resistance Mechanisms
  • Pharmaceutical studies and practices
  • Cardiac electrophysiology and arrhythmias
  • Pharmaceutical studies and practices
  • Optimal Experimental Design Methods
  • Health Systems, Economic Evaluations, Quality of Life
  • Health Systems, Economic Evaluations, Quality of Life
  • Gene Regulatory Network Analysis
  • Gene Regulatory Network Analysis
  • Biosimilars and Bioanalytical Methods
  • Biosimilars and Bioanalytical Methods
  • Anesthesia and Sedative Agents
  • Mathematical Biology Tumor Growth
  • Control Systems and Identification
  • HER2/EGFR in Cancer Research
  • Mathematical Biology Tumor Growth
  • HER2/EGFR in Cancer Research
  • Anesthesia and Sedative Agents
  • Anesthesia and Sedative Agents
  • Advanced Causal Inference Techniques
  • Advanced Causal Inference Techniques
  • Pharmacological Effects and Toxicity Studies
  • Pharmacological Effects and Toxicity Studies
  • Drug Solubulity and Delivery Systems
  • Cancer Treatment and Pharmacology
  • Cancer Treatment and Pharmacology
  • Analytical Methods in Pharmaceuticals
  • Analytical Methods in Pharmaceuticals
  • Barrier Structure and Function Studies
  • Diabetes Management and Research
  • Drug Solubulity and Delivery Systems
  • Drug Solubulity and Delivery Systems
  • Gene Regulatory Network Analysis
  • Diabetes Treatment and Management
  • Cancer Immunotherapy and Biomarkers
  • History of Science and Medicine
  • Cancer Cells and Metastasis
  • Medication Adherence and Compliance
  • Veterinary Pharmacology and Anesthesia
  • Nanoparticle-Based Drug Delivery

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: